共 50 条
- [21] Indolinone based phosphoinositide-dependent kinase-1 (PDK1) inhibitors. Part 2: Optimization of BX-517BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (14) : 3819 - 3825Islam, ImadulBrown, GregBryant, JudiHrvatin, PaulKochanny, Monica J.Phillips, Gary B.Yuan, ShendongAdler, MarcWhitlow, MarcLentz, DaoPolokoff, Mark A.Wu, JamesShen, JunWalters, JanetteHo, ElenaSubramanyam, BabuZhu, DaguangFeldman, Richard I.Arnaiz, Damian O.
- [22] Acetylenic TACE inhibitors. Part 2: SAR of six-membered cyclic sulfonamide hydroxamatesBIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (19) : 4345 - 4349Levin, JIChen, JMLaakso, LMDu, MDu, XVenkatesan, AMSandanayaka, VZask, AXu, JXu, WZhang, YSkotnicki, JS
- [23] HCV NS5A replication complex inhibitors. Part 2: Investigation of stilbene prolinamidesBIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (19) : 6063 - 6066St Laurent, Denis R.Belema, MakonenGao, MinGoodrich, JasonKakarla, RameshKnipe, Jay O.Lemm, Julie A.Liu, MengpingLopez, Omar D.Nguyen, Van N.Nower, Peter T.O'Boyle, Donald, IIQiu, YupingRomine, Jeffrey L.Serrano-Wu, Michael H.Sun, Jin-HuaValera, LourdesYang, FukangYang, XuejieMeanwell, Nicholas A.Snyder, Lawrence B.
- [24] Respiratory syncytial virus fusion inhibitors. Part 5: Optimization of benzimidazole substitution patterns towards derivatives with improved activityBIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (16) : 4592 - 4598Wang, Xiangdong AlanCianci, Christopher W.Yu, Kuo-LongCombrink, Keith D.Thuring, Jan W.Zhang, YiCiviello, Rita L.Kadow, Kathleen F.Roach, JuliaLi, ZhufangLangley, David R.Krystal, MarkMeanwell, Nicholas A.
- [25] In vivo and in vitro SAR of tetracyclic MAPKAP-K2 (MK2) inhibitors. Part IBIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (15) : 4715 - 4718Revesz, LaszloSchlapbach, AchimAichholz, ReinerFeifel, RolandHawtin, StuartHeng, RichardHiestand, PeterJahnke, WolfgangKoch, GuidoKroemer, MarkusMoebitz, HenrikScheufler, ClemensVelcicky, JurajHuppertz, Christine
- [26] Respiratory syncytial virus fusion inhibitors. Part 4: Optimization for oral bioavailability (vol 17, pg 895, 2007)BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (08) : 2385 - 2385Yu, Kuo-LongSin, NyCiviello, Rita L.Wang, X. AlanCombrink, Keith D.Gulgeze, H. BelginVenables, Brian L.Wright, J. J. KimDalterio, Richard A.Zadjura, LisaMarino, AnthonyDando, SandraD'Arienzo, CeliaKadow, Kathleen F.Cianci, Christopher W.Li, ZhufangClarke, JuniusGenovesi, Eugene V.Medina, IvetteLamb, LucindaColonno, Richard J.Yang, ZhengKrystal, MarkMeanwell, Nicholas A.
- [27] Design and synthesis of pyrimidoindolone Caspase-3 inhibitors: Part 2 - Sulfonamide modificationsABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2682 - U2682Havran, Lisa M.Childers, Wayne E., Jr.Marathias, VasiliosAulabaugh, AnnChan, HelenCho, SeongeunCowling, RebeccaFennel, MylesHarrison, Boyd L.Hum, Wah-TungKapoor, BhupeshLing, Huai-PingMagolda, Ronald L.Mosyak, LidiaRobichaud, Albert J.Xu, WeixinWood, Andrew
- [28] Optimization of the β-aminoester class of factor Xa inhibitors.: Part 2:: Identification of FXV673 as a potent and selective inhibitor with excellent in vivo anticoagulant activityBIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (12) : 1671 - 1674Guertin, KRGardner, CJKlein, SIZulli, ALCzekaj, MGong, YSpada, APCheney, DLMaignan, SGuilloteau, JPBrown, KDColussi, DJChu, VHeran, CLMorgan, SRBentley, RGDunwiddie, CTLeadley, RJPauls, HW
- [29] 4-Aminopyrimidine-5-carbaldehyde oximes as potent VEGFR-2 inhibitors. Part IIBIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (06) : 1815 - 1818Huang, ShenlinLi, RonghuaLaMontagne, Kenneth R.Greenberger, Lee M.Connolly, Peter J.
- [30] Anthranilate sulfonamide hydroxamate TACE inhibitors.: Part 2:: SAR of the acetylenic P1′ groupBIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (08) : 1199 - 1202Levin, JIChen, JMDu, MTNelson, FCKillar, LMSkala, SSung, AJin, GCowling, RBarone, DMarch, CJMohler, KMBlack, RASkotnicki, JS